Clinical trial
SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
NCT04889183 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
- Lead sponsor
- University Medical Center Groningen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 14, 2022
- Completion date
- May 28, 2024
- Enrollment
- 125 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.